Drug Shortage Report for OBIZUR

Last updated on 2020-07-31 History
Report ID 121439
Drug Identification Number 02447401
Brand name OBIZUR
Common or Proper name Antihemophilic Factor (Recombinant), Porcine Sequence
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) ANTIHEMOPHILIC FACTOR
Strength(s) 500UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3 mL single-dose vial
ATC code B02BD
ATC description VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-07-30
Actual start date 2020-07-30
Estimated end date 2020-09-15
Actual end date
Shortage status Actual shortage
Updated date 2020-07-31
Company comments
Health Canada comments
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-07-31 English Compare
v2 2020-07-30 French Compare
v1 2020-07-30 English Compare